Elsevier Read & Publish

The agreement consists of a reading part and a publishing part. We will update this web page with more information and author instructions later on.

Publishing part (to take effect 1 January 2020)

The agreement covers publishing fees for manuscripts submitted from 1 January 2020 onwards.

In short, the following material is covered:

  • Elsevier hybrid and fully open access titles, including society journals. Title list (pdf*)
  • Cell Press hybrid and fully open acces titles. Title list (pdf*)
  • Fully open access titles from the Lancet journals (Note: not The Lancet). Title list (pdf*)

The agreement allows publishing with CC-BY license (or another open license, according to the author's wishes).

Reading part (to take effect 3 December* 2019)

  • Reading rights to the Science Direct Freedom Collection (approximately 2,000 journals) from 1995 onwards.
  • Cell Press (14 journals). Title list (pdf)
  • The Lancet, Lancet Infectious Diseases, Lancet Neurology and Lancet Oncology.

Please contact Research Support at the library if you have questions about the Elsevier agreement or publishing in general.

*With reservation for minor alterations regarding title lists and when the reading part comes into effect.

Senast uppdaterad: 
2019-12-11